Quality of life in a community sample of young cocaine and/or heroin users: the role of mental disorders

Quality of Life Research

Volumn 24, Issue 9, 2015, Pages 2129-2137

  Chahua, M ^a   Sanchez Niubo A ^b   Torrens, M ^b,c   Sordo, L ^d,e,f   Bravo, M J ^d,f   Brugal, M T ^g,h   Domingo Salvany, A ^b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d CARLOS III INSTITUTE OF HEALTH   (Spain)

^e UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g AGÈNCIA DE SALUT PÚBLICA DE BARCELONA   (Spain)

^h BIOMEDICAL RESEARCH INSTITUTE SANT PAU IIB SANT PAU   (Spain)

Author keywords

Borderline personality disorder; Illicit drug users; PRISM; Psychotic disorders; Quality of life; Substance use disorder

Indexed keywords

ADOLESCENT; ADULT; COCAINE DEPENDENCE; COMPLICATION; CROSS-SECTIONAL STUDY; DRUG USE; FEMALE; HEROIN DEPENDENCE; HUMAN; MALE; MENTAL DISEASE; PSYCHOLOGY; QUALITY OF LIFE; SPAIN; YOUNG ADULT;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; DRUG USERS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; MENTAL DISORDERS; QUALITY OF LIFE; SPAIN; YOUNG ADULT;

EID: 84938954693     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-015-0943-5     Document Type: Article

References (59)

1. European Monitoring Center for Drugs and Drug Addiction. (2012). The state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.
2. Giacomuzzi, S. M., Ertl, M., Kemmler, G., Riemer, Y., & Vigl, A. (2005). Sublingual buprenorphine and methadone maintenance treatment: A three-year follow-up of quality of life assessment. Scientific World Journal,5, 452–468.
3. Iraurgi, I., Póo, M., & Márkez, I. (2004). Evaluation of the SF-36 health index applied to methadone maintenance program users. Reference values for the Basque Autonomous Community, Spain. Revista Española de Salud Publica,78(5), 609–621.
4. Torrens, M., San, L., Martinez, A., Castillo, C., Domingo-Salvany, A., & Alonso, J. (1997). Use of the Nottingham health profile for measuring health status of patients in methadone maintenance treatment. Addiction,92(6), 707–716.
5. Millson, P. E., Challacombe, L., Villeneuve, P. J., Fischer, B., Strike, C. J., Myers, T., et al. (2004). Self-perceived health among Canadian opiate users: A comparison to the general population and to other chronic disease populations. Canadian Journal of Public Health,95(2), 99–103.
6. Nemeth, G. (2006). Health related quality of life outcome instruments. European Spine Journal,15(Suppl. 1), S44–S51.
7. Baum, M. K., Jayaweera, D. T., Duan, R., Sales, S., Lai, S., Rafie, C., et al. (2008). Quality of life, symptomatology and healthcare utilization in HIV/HCV co-infected drug users in Miami. Journal of Addictive Diseases,27(2), 37–48.
8. Falck, R. S., Wang, J., Carlson, R. G., & Siegal, H. A. (2000). Crack-cocaine use and health status as defined by the SF-36. Addictive Behaviors,25(4), 579–584.
9. Puigdollers, E., Domingo-Salvany, A., Brugal, M. T., Torrens, M., Alvaros, J., Castillo, C., et al. (2004). Characteristics of heroin addicts entering methadone maintenance treatment: Quality of life and gender. Substance Use and Misuse,39(9), 1353–1368.
10. Tiffany, S. T., Friedman, L., Greenfield, S. F., Hasin, D. S., & Jackson, R. (2012). Beyond drug use: A systematic consideration of other outcomes in evaluations of treatments for substance use disorders. Addiction,107(4), 709–718.
11. Comer, J. S., Blanco, C., Hasin, D. S., Liu, S. M., Grant, B. F., Turner, J. B., & Olfson, M. (2011). Health-related quality of life across the anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions (NESARC). The Journal of Clinical Psychiatry,72(1), 43–50.
12. Kessler, R. C., Aguilar-Gaxiola, S., Alonso, J., Chatterji, S., Lee, S., Ormel, J., et al. (2009). The global burden of mental disorders: An update from the WHO world mental health (WMH) surveys. Epidemiologia e Psichiatria Sociale,18(1), 23–33.
13. Perseius, K. I., Andersson, E., Asberg, M., & Samuelsson, M. (2006). Health-related quality of life in women patients with borderline personality disorder. Scandinavian Journal of Caring Sciences,20(3), 302–307.
14. Piccinni, A., Catena, M., Del, D. A., Marazziti, D., Monje, C., Schiavi, E., et al. (2007). Health-related quality of life and functioning in remitted bipolar I outpatients. Comprehensive Psychiatry,48(4), 323–328.
15. Rubio, J. M., Olfson, M., Villegas, L., Perez-Fuentes, G., Wang, S., & Blanco, C. (2013). Quality of life following remission of mental disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of Clinical Psychiatry,74(5), e445–e450.
16. Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry,64(5), 566–576.
17. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry,61(8), 807–816.
18. Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., & Ruan, W. J. (2005). Co-occurrence of DSM-IV personality disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Comprehensive Psychiatry,46(1), 1–5.
19. Hasin, D., Fenton, M. C., Skodol, A., Krueger, R., Keyes, K., Geier, T., et al. (2011). Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders. Archives of General Psychiatry,68(11), 1158–1167.
20. Hasin, D. S., Stinson, F. S., Ogburn, E., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Archives of General Psychiatry,64(7), 830–842.
21. Aharonovich, E., Liu, X., Nunes, E., & Hasin, D. S. (2002). Suicide attempts in substance abusers: Effects of major depression in relation to substance use disorders. The American Journal of Psychiatry,159(9), 1600–1602.
22. Burns, L., Teesson, M., & O’Neill, K. (2005). The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction,100(6), 787–796.
23. King, V. L., Kidorf, M. S., Stoller, K. B., & Brooner, R. K. (2000). Influence of psychiatric comorbidity on HIV risk behaviors: Changes during drug abuse treatment. Journal of Addictive Diseases,19(4), 65–83.
24. Curran, G. M., Sullivan, G., Williams, K., Han, X., Collins, K., Keys, J., & Kotrla, K. J. (2003). Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Annals of Emergency Medicine,41(5), 659–667.
25. Lejoyeux, M., Boulenguiez, S., Fichelle, A., McLoughlin, M., Claudon, M., & Ades, J. (2000). Alcohol dependence among patients admitted to psychiatric emergency services. General Hospital Psychiatry,22(3), 206–212.
26. Martín-Santos, R., Fonseca, F., Domingo-Salvany, A., Ginés, J. M., Ímaz, M. L., Navinés, R., et al. (2006). Dual diagnosis in the psychiatric emergency room in Spain. The European Journal of Psychiatry,20, 147–156.
27. Astals, M., Domingo-Salvany, A., Buenaventura, C. C., Tato, J., Vázquez, J. M., Martín-Santos, R., & Torrens, M. (2008). Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Substance Use and Misuse,43(5), 612–632.
28. Bizzarri, J., Rucci, P., Vallotta, A., Girelli, M., Scandolari, A., Zerbetto, E., et al. (2005). Dual diagnosis and quality of life in patients in treatment for opioid dependence. Substance Use and Misuse,40(12), 1765–1776.
29. Carpentier, P. J., Krabbe, P. F., van Gogh, M. T., Knapen, L. J., Buitelaar, J. K., & de Jong, C. A. (2009). Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal on Addictions,18(6), 470–480.
30. Domingo-Salvany, A., Brugal, M. T., Barrio, G., Gonzalez-Saiz, F., Bravo, M. J., & de la Fuente, L. (2010). Gender differences in health related quality of life of young heroin users. Health and Quality of Life Outcomes,8, 145.
31. Lozano, O. M., Domingo-Salvany, A., Martinez-Alonso, M., Brugal, M. T., Alonso, J., & de la Fuente, L. (2008). Health-related quality of life in young cocaine users and associated factors. Quality of Life Research,17(7), 977–985.
32. Herrero, M. J., Domingo-Salvany, A., Torrens, M., & Brugal, M. T. (2008). Psychiatric comorbidity in young cocaine users: Induced versus independent disorders. Addiction,103(2), 284–293.
33. Rodríguez-Llera, M. C., Domingo-Salvany, A., Brugal, M. T., Silva, T. C., Sánchez-Niubó, A., & Torrens, M. (2006). Psychiatric comorbidity in young heroin users. Drug and Alcohol Dependence,84(1), 48–55.
34. de la Fuente, L., Brugal, M. T., Ballesta, R., Bravo, M. J., Barrio, G., Domingo-Salvany, A., et al. (2005). Cohort study methodology of the ITINERE project on heroin users in three Spanish cities and main characteristics of the participants. Revista Española de Salud Publica,79(4), 475–491.
35. Pulido, J., Brugal, M. T., de la Fuente, L., Ballesta, R., Barrio, G., Bravo, M. J., et al. (2009). Recruitment methodology and characteristics of a cohort of young regular cocaine users in three Spanish cities (the itinere-cocaine project). Gaceta Sanitaria,23(3), 200–207.
36. Heckathorn, D. D. (2011). Snowball versus respondent-driven sampling. Sociological Methodology,41(1), 355–366.
37. Alonso, J., Anto, J. M., & Moreno, C. (1990). Spanish version of the Nottingham health profile: Translation and preliminary validity. American Journal of Public Health,80(6), 704–708.
38. Torrens, M., Serrano, D., Astals, M., Pérez-Domínguez, G., & Martín-Santos, R. (2004). Diagnosing comorbid psychiatric disorders in substance abusers: Validity of the Spanish versions of the psychiatric research interview for substance and mental disorders and the structured clinical interview for DSM-IV. The American Journal of Psychiatry,161(7), 1231–1237.
39. Hasin, D., Samet, S., Nunes, E., Meydan, J., Matseoane, K., & Waxman, R. (2006). Diagnosis of comorbid psychiatric disorders in substance users assessed with the psychiatric research interview for substance and mental disorders for DSM-IV. The American Journal of Psychiatry,163(4), 689–696.
40. González-Sáiz, F., De las Cuevas, C., Barrio, G., & Domingo-Salvany, A. (2008). Versión española consensuada de la severity of dependence scale (SDS). Medicina Clinica,131(20), 797.
41. Gossop, M., Darke, S., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995). The severity of dependence scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction,90(5), 607–614.
42. Tobin, J. (1958). Estimation of relationships for limited dependent variables. Econometrica, 26(1), 24–36.
43. Bleda, M. J., & Tobias, A. (2002). Application of tobit regression models in modelling censored epidemiological variables. Gaceta Sanitaria,16(2), 188–195.
44. Greene, W. (1997). Econometric analysis (3rd ed.). Saddle River, New Jersey: Prentice Hall.
45. SPSS Inc. & IBM Company. (2010). Statistical program for the social sciences. SPSS.
46. Core Team, R. (2012). R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
47. Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
48. González-Sáiz, F., Domingo-Salvany, A., Barrio, G., Sánchez-Niubò, A., Brugal, M. T., de la Fuente, L., & Alonso, J. (2009). Severity of dependence scale as a diagnostic tool for heroin and cocaine dependence. European Addiction Research,15(2), 87–93.
49. Alonso, J., Prieto, L., & Anto, J. M. (1994). The Spanish version of the Nottingham health profile: A review of adaptation and instrument characteristics. Quality of Life Research,3(6), 385–393.
50. Ware, J. E., Kosinski, M., Turner-Bowker, D. M., & Gandek, B. (2002). How to score version 2 of the SF-12 health survey. Lincoln, RI: Quality Metrics.
51. Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., et al. (2006). Substance use in persons with schizophrenia: Baseline prevalence and correlates from the NIMH CATIE study. The Journal of Nervous and Mental Disease,194(3), 164–172.
52. Owen, R. R., Fischer, E. P., Booth, B. M., & Cuffel, B. J. (1996). Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services,47(8), 853–858.
53. Linszen, D. H., Dingemans, P. M., & Lenior, M. E. (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry,51(4), 273–279.
54. Eack, S. M., & Newhill, C. E. (2007). Psychiatric symptoms and quality of life in schizophrenia: A meta-analysis. Schizophrenia Bulletin,33(5), 1225–1237.
55. Gibbie, T. M., Hides, L. M., Cotton, S. M., Lubman, D. I., Aitken, C., & Hellard, M. (2011). The relationship between personality disorders and mental health, substance use severity and quality of life among injecting drug users. The Medical Journal of Australia,195(3), S16–S21.
56. Soeteman, D. I., Hakkaart-van, R. L., Verheul, R., & Busschbach, J. J. (2008). The economic burden of personality disorders in mental health care. The Journal of Clinical Psychiatry,69(2), 259–265.
57. Jackson, H. J., & Burgess, P. M. (2000). Personality disorders in the community: A report from the Australian National Survey of Mental Health and Wellbeing. Social Psychiatry and Psychiatric Epidemiology,35(12), 531–538.
58. Masthoff, E. D., Trompenaars, F. J., van Heck, G. L., Michielsen, H. J., Hodiamont, P. P., & De Vries, J. (2007). Predictors of quality of life: A model based study. Quality of Life Research,16(2), 309–320.
59. Del Boca, F. K., & Darkes, J. (2003). The validity of self-reports of alcohol consumption: State of the science and challenges for research. Addiction,98(Suppl. 2), 1–12.